| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptor-Interacting Protein Serine-Threonine Kinases | 36 | 2025 | 78 | 6.320 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 26 | 2024 | 49 | 6.140 |
Why?
|
| Apoptosis | 38 | 2024 | 1038 | 3.550 |
Why?
|
| Proto-Oncogene Proteins c-myc | 11 | 2024 | 99 | 2.610 |
Why?
|
| Receptor, Notch1 | 13 | 2024 | 61 | 2.210 |
Why?
|
| Proto-Oncogene Proteins | 19 | 2017 | 315 | 2.190 |
Why?
|
| Tumor Necrosis Factor-alpha | 15 | 2021 | 582 | 2.090 |
Why?
|
| Necrosis | 13 | 2024 | 138 | 2.030 |
Why?
|
| Mice | 78 | 2025 | 10272 | 1.720 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 14 | 2017 | 123 | 1.690 |
Why?
|
| T-Cell Acute Lymphocytic Leukemia Protein 1 | 14 | 2024 | 22 | 1.680 |
Why?
|
| Animals | 94 | 2025 | 19641 | 1.510 |
Why?
|
| NF-kappa B | 19 | 2018 | 461 | 1.470 |
Why?
|
| Macrophages | 13 | 2025 | 1004 | 1.350 |
Why?
|
| DNA-Binding Proteins | 10 | 2018 | 1131 | 1.270 |
Why?
|
| Inflammation | 11 | 2025 | 1097 | 1.190 |
Why?
|
| Oncogenes | 8 | 2024 | 68 | 1.170 |
Why?
|
| Bone Marrow | 4 | 2019 | 174 | 1.150 |
Why?
|
| LIM Domain Proteins | 4 | 2024 | 29 | 1.130 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2020 | 48 | 1.130 |
Why?
|
| GTPase-Activating Proteins | 4 | 2011 | 64 | 1.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 6 | 2024 | 416 | 1.020 |
Why?
|
| Cell Transformation, Neoplastic | 6 | 2014 | 192 | 1.010 |
Why?
|
| Cell Line, Tumor | 23 | 2025 | 1373 | 1.010 |
Why?
|
| Thymus Gland | 10 | 2024 | 222 | 0.980 |
Why?
|
| Signal Transduction | 27 | 2025 | 2886 | 0.950 |
Why?
|
| Caspase 8 | 10 | 2025 | 61 | 0.940 |
Why?
|
| Disease Models, Animal | 13 | 2019 | 2067 | 0.930 |
Why?
|
| Mice, Knockout | 24 | 2025 | 1988 | 0.920 |
Why?
|
| Leukemia, T-Cell | 3 | 2010 | 5 | 0.920 |
Why?
|
| Transcription Factors | 10 | 2024 | 1456 | 0.910 |
Why?
|
| Gene Expression Regulation, Neoplastic | 7 | 2025 | 483 | 0.910 |
Why?
|
| Pancytopenia | 1 | 2024 | 7 | 0.910 |
Why?
|
| T-Lymphocytes | 7 | 2022 | 964 | 0.890 |
Why?
|
| Cells, Cultured | 21 | 2019 | 2099 | 0.890 |
Why?
|
| Nod2 Signaling Adaptor Protein | 5 | 2013 | 26 | 0.880 |
Why?
|
| Mice, Transgenic | 21 | 2018 | 1223 | 0.870 |
Why?
|
| MAP Kinase Kinase Kinases | 8 | 2020 | 74 | 0.860 |
Why?
|
| Nucleic Acids | 1 | 2024 | 50 | 0.840 |
Why?
|
| Neoplastic Stem Cells | 5 | 2024 | 201 | 0.790 |
Why?
|
| Metalloproteins | 3 | 2011 | 13 | 0.790 |
Why?
|
| Neoplasms | 3 | 2023 | 1244 | 0.780 |
Why?
|
| Receptors, Notch | 3 | 2018 | 100 | 0.760 |
Why?
|
| Glucocorticoids | 2 | 2020 | 172 | 0.750 |
Why?
|
| Amyloid Precursor Protein Secretases | 6 | 2018 | 62 | 0.750 |
Why?
|
| Second Messenger Systems | 1 | 2021 | 26 | 0.730 |
Why?
|
| Gene Expression Regulation, Leukemic | 12 | 2024 | 46 | 0.730 |
Why?
|
| Dinoprostone | 1 | 2021 | 46 | 0.730 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 5 | 2006 | 10 | 0.720 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 7 | 2018 | 324 | 0.710 |
Why?
|
| Dexamethasone | 2 | 2021 | 194 | 0.700 |
Why?
|
| Cyclic AMP | 1 | 2021 | 142 | 0.700 |
Why?
|
| Cell Death | 8 | 2024 | 268 | 0.660 |
Why?
|
| Proteins | 9 | 2018 | 740 | 0.660 |
Why?
|
| Drug Resistance, Neoplasm | 6 | 2021 | 183 | 0.650 |
Why?
|
| Mitogen-Activated Protein Kinases | 5 | 2005 | 201 | 0.650 |
Why?
|
| Cell Proliferation | 6 | 2024 | 942 | 0.640 |
Why?
|
| Ubiquitin | 7 | 2018 | 95 | 0.620 |
Why?
|
| Mice, Inbred C57BL | 24 | 2019 | 3192 | 0.620 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 2 | 2024 | 82 | 0.610 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2018 | 68 | 0.610 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2024 | 100 | 0.610 |
Why?
|
| Proto-Oncogene Proteins c-myb | 2 | 2017 | 11 | 0.600 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2018 | 42 | 0.590 |
Why?
|
| Cell Cycle Proteins | 6 | 2017 | 376 | 0.580 |
Why?
|
| Hematopoietic Stem Cells | 6 | 2024 | 273 | 0.580 |
Why?
|
| Immunity, Cellular | 1 | 2018 | 176 | 0.580 |
Why?
|
| RNA, Small Interfering | 5 | 2021 | 851 | 0.570 |
Why?
|
| Humans | 61 | 2025 | 59422 | 0.570 |
Why?
|
| Liver | 6 | 2018 | 784 | 0.560 |
Why?
|
| Immunity | 1 | 2017 | 96 | 0.550 |
Why?
|
| Endothelium, Vascular | 1 | 2018 | 172 | 0.550 |
Why?
|
| Shock, Septic | 1 | 2018 | 90 | 0.540 |
Why?
|
| Antineoplastic Agents | 6 | 2017 | 645 | 0.540 |
Why?
|
| Multiprotein Complexes | 3 | 2017 | 150 | 0.530 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2014 | 185 | 0.530 |
Why?
|
| Intestinal Mucosa | 5 | 2019 | 220 | 0.520 |
Why?
|
| Autoimmunity | 1 | 2017 | 221 | 0.520 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 4 | 2019 | 125 | 0.510 |
Why?
|
| Xenograft Model Antitumor Assays | 7 | 2025 | 180 | 0.510 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2014 | 115 | 0.510 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 7 | 2018 | 83 | 0.510 |
Why?
|
| Tuberculosis | 2 | 2009 | 262 | 0.490 |
Why?
|
| Gene Deletion | 6 | 2019 | 298 | 0.480 |
Why?
|
| I-kappa B Kinase | 8 | 2019 | 48 | 0.470 |
Why?
|
| Dendritic Cells | 1 | 2017 | 508 | 0.470 |
Why?
|
| Hypothermia | 1 | 2014 | 19 | 0.460 |
Why?
|
| Acetylmuramyl-Alanyl-Isoglutamine | 3 | 2009 | 10 | 0.460 |
Why?
|
| Clonal Evolution | 1 | 2014 | 3 | 0.460 |
Why?
|
| Homeodomain Proteins | 4 | 2024 | 255 | 0.460 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2025 | 54 | 0.460 |
Why?
|
| Flow Cytometry | 7 | 2014 | 638 | 0.450 |
Why?
|
| Mycobacterium tuberculosis | 2 | 2009 | 383 | 0.450 |
Why?
|
| Induction Chemotherapy | 1 | 2014 | 33 | 0.440 |
Why?
|
| Interferon Type I | 2 | 2016 | 167 | 0.410 |
Why?
|
| Antigens, CD | 6 | 2006 | 343 | 0.400 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 9 | 2014 | 23 | 0.390 |
Why?
|
| Neoplasm Proteins | 5 | 2021 | 276 | 0.390 |
Why?
|
| Receptors, Tumor Necrosis Factor | 6 | 2004 | 61 | 0.380 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2011 | 44 | 0.370 |
Why?
|
| Receptors, Glucocorticoid | 2 | 2021 | 27 | 0.360 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2011 | 194 | 0.360 |
Why?
|
| Acyltransferases | 2 | 2024 | 32 | 0.360 |
Why?
|
| DNA Damage | 2 | 2016 | 280 | 0.350 |
Why?
|
| Nuclear Proteins | 3 | 2024 | 758 | 0.350 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2009 | 52 | 0.340 |
Why?
|
| Gene Expression | 5 | 2020 | 807 | 0.340 |
Why?
|
| Protein Kinases | 3 | 2019 | 139 | 0.330 |
Why?
|
| Lymphoma | 4 | 2016 | 99 | 0.330 |
Why?
|
| Interferon Regulatory Factors | 1 | 2009 | 39 | 0.330 |
Why?
|
| Cyclic S-Oxides | 1 | 2009 | 1 | 0.330 |
Why?
|
| Thiadiazoles | 1 | 2009 | 5 | 0.320 |
Why?
|
| Interferon Regulatory Factor-3 | 2 | 2009 | 91 | 0.320 |
Why?
|
| Myeloid Differentiation Factor 88 | 5 | 2017 | 207 | 0.320 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2009 | 48 | 0.320 |
Why?
|
| Toll-Like Receptor 4 | 5 | 2017 | 348 | 0.320 |
Why?
|
| Nerve Degeneration | 2 | 2016 | 68 | 0.310 |
Why?
|
| TCF Transcription Factors | 3 | 2021 | 6 | 0.300 |
Why?
|
| Cell Survival | 8 | 2017 | 557 | 0.300 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 3 | 2016 | 40 | 0.300 |
Why?
|
| Thymus Neoplasms | 4 | 2005 | 21 | 0.300 |
Why?
|
| Promoter Regions, Genetic | 4 | 2024 | 659 | 0.290 |
Why?
|
| Cytokines | 6 | 2017 | 905 | 0.290 |
Why?
|
| Gene Expression Profiling | 7 | 2017 | 702 | 0.290 |
Why?
|
| Ubiquitination | 1 | 2007 | 106 | 0.280 |
Why?
|
| Mice, Mutant Strains | 4 | 2018 | 304 | 0.280 |
Why?
|
| Toll-Like Receptors | 5 | 2017 | 434 | 0.270 |
Why?
|
| Neutrophils | 2 | 2019 | 352 | 0.270 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2006 | 12 | 0.270 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2018 | 148 | 0.270 |
Why?
|
| Transcription, Genetic | 5 | 2018 | 847 | 0.270 |
Why?
|
| Transcription Factor RelA | 4 | 2019 | 47 | 0.270 |
Why?
|
| Child | 4 | 2022 | 4306 | 0.260 |
Why?
|
| Adjuvants, Immunologic | 1 | 2007 | 228 | 0.260 |
Why?
|
| Toll-Like Receptor 3 | 2 | 2005 | 67 | 0.260 |
Why?
|
| Lipopolysaccharides | 5 | 2017 | 645 | 0.260 |
Why?
|
| Mutation | 8 | 2013 | 2443 | 0.260 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2018 | 105 | 0.250 |
Why?
|
| Enzyme Inhibitors | 4 | 2014 | 341 | 0.250 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2017 | 98 | 0.250 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 | 2016 | 68 | 0.250 |
Why?
|
| Immunophenotyping | 4 | 2011 | 185 | 0.240 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2025 | 8 | 0.240 |
Why?
|
| Sarcoma, Ewing | 1 | 2025 | 11 | 0.240 |
Why?
|
| Galactosyltransferases | 1 | 2025 | 17 | 0.240 |
Why?
|
| Carcinogenesis | 2 | 2016 | 116 | 0.240 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2016 | 299 | 0.240 |
Why?
|
| DNA | 4 | 2007 | 792 | 0.240 |
Why?
|
| Pyroptosis | 1 | 2025 | 32 | 0.230 |
Why?
|
| Radiation Chimera | 2 | 2021 | 57 | 0.230 |
Why?
|
| WNK Lysine-Deficient Protein Kinase 1 | 1 | 2024 | 5 | 0.230 |
Why?
|
| Female | 21 | 2025 | 30883 | 0.230 |
Why?
|
| CD24 Antigen | 1 | 2024 | 16 | 0.230 |
Why?
|
| Epithelial Cells | 3 | 2019 | 374 | 0.230 |
Why?
|
| Carrier Proteins | 1 | 2009 | 709 | 0.230 |
Why?
|
| Enzyme Activation | 7 | 2007 | 353 | 0.230 |
Why?
|
| Phosphorylation | 8 | 2017 | 858 | 0.230 |
Why?
|
| Blotting, Western | 5 | 2012 | 593 | 0.220 |
Why?
|
| Leukemia | 2 | 2016 | 53 | 0.220 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 1129 | 0.220 |
Why?
|
| Chromatin | 3 | 2017 | 594 | 0.220 |
Why?
|
| Transcriptional Activation | 3 | 2018 | 188 | 0.220 |
Why?
|
| RNA Splicing | 1 | 2025 | 160 | 0.220 |
Why?
|
| Casein Kinase II | 3 | 2016 | 15 | 0.220 |
Why?
|
| Male | 18 | 2021 | 27545 | 0.210 |
Why?
|
| Alzheimer Disease | 2 | 2017 | 551 | 0.210 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 2022 | 8 | 0.210 |
Why?
|
| Ovarian Neoplasms | 1 | 2024 | 135 | 0.210 |
Why?
|
| Ubiquitin-Protein Ligases | 5 | 2017 | 207 | 0.210 |
Why?
|
| Ligands | 3 | 2018 | 420 | 0.210 |
Why?
|
| Precancerous Conditions | 1 | 2003 | 72 | 0.210 |
Why?
|
| Immunity, Innate | 5 | 2016 | 762 | 0.210 |
Why?
|
| Molecular Targeted Therapy | 2 | 2021 | 118 | 0.210 |
Why?
|
| Phagocytosis | 1 | 2024 | 252 | 0.210 |
Why?
|
| Genes, abl | 2 | 1993 | 9 | 0.210 |
Why?
|
| DNA Helicases | 1 | 2024 | 187 | 0.200 |
Why?
|
| TNF Receptor-Associated Factor 2 | 5 | 2005 | 11 | 0.200 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 3 | 2022 | 53 | 0.200 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2024 | 229 | 0.200 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 2 | 2019 | 25 | 0.200 |
Why?
|
| Tumor Cells, Cultured | 3 | 2012 | 454 | 0.190 |
Why?
|
| Proteolysis | 3 | 2018 | 137 | 0.190 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 2001 | 12 | 0.190 |
Why?
|
| Presenilin-1 | 2 | 2017 | 53 | 0.190 |
Why?
|
| Receptors, Prostaglandin E, EP4 Subtype | 1 | 2021 | 5 | 0.190 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 2021 | 12 | 0.190 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2021 | 11 | 0.190 |
Why?
|
| Colforsin | 1 | 2021 | 24 | 0.180 |
Why?
|
| Chromogranins | 1 | 2021 | 11 | 0.180 |
Why?
|
| Protein Binding | 4 | 2017 | 1548 | 0.180 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2022 | 279 | 0.180 |
Why?
|
| Immunotherapy | 1 | 2023 | 231 | 0.180 |
Why?
|
| Fusion Proteins, bcr-abl | 4 | 2016 | 32 | 0.180 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinase 2 | 3 | 2009 | 9 | 0.170 |
Why?
|
| Models, Animal | 1 | 2021 | 221 | 0.170 |
Why?
|
| Gene Silencing | 2 | 2014 | 376 | 0.170 |
Why?
|
| Radiation Tolerance | 2 | 2016 | 49 | 0.170 |
Why?
|
| Heterografts | 2 | 2018 | 60 | 0.170 |
Why?
|
| Receptors, Estrogen | 1 | 2020 | 124 | 0.170 |
Why?
|
| Crohn Disease | 2 | 2019 | 113 | 0.170 |
Why?
|
| Azepines | 2 | 2016 | 19 | 0.170 |
Why?
|
| RNA Interference | 2 | 2021 | 590 | 0.160 |
Why?
|
| Membrane Proteins | 4 | 2025 | 841 | 0.160 |
Why?
|
| Paneth Cells | 2 | 2016 | 5 | 0.160 |
Why?
|
| Sequence Analysis, DNA | 2 | 2018 | 397 | 0.160 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2019 | 8 | 0.160 |
Why?
|
| Triazoles | 2 | 2016 | 53 | 0.160 |
Why?
|
| Multiple Myeloma | 1 | 2024 | 323 | 0.160 |
Why?
|
| Gene Knock-In Techniques | 2 | 2019 | 34 | 0.160 |
Why?
|
| Transfection | 5 | 2017 | 674 | 0.160 |
Why?
|
| Tumor Necrosis Factor alpha-Induced Protein 3 | 1 | 2018 | 4 | 0.160 |
Why?
|
| Host-Pathogen Interactions | 2 | 2018 | 238 | 0.160 |
Why?
|
| Gene Regulatory Networks | 2 | 2012 | 139 | 0.160 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2018 | 19 | 0.160 |
Why?
|
| Homeostasis | 3 | 2014 | 342 | 0.160 |
Why?
|
| Plague | 1 | 2018 | 23 | 0.160 |
Why?
|
| Colitis, Ulcerative | 1 | 2019 | 84 | 0.150 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2018 | 11 | 0.150 |
Why?
|
| MAP Kinase Signaling System | 2 | 2014 | 201 | 0.150 |
Why?
|
| Genes, Lethal | 2 | 2014 | 41 | 0.150 |
Why?
|
| Mice, 129 Strain | 1 | 2018 | 40 | 0.150 |
Why?
|
| Extracellular Traps | 1 | 2018 | 39 | 0.150 |
Why?
|
| Interleukin-1alpha | 2 | 2019 | 25 | 0.150 |
Why?
|
| Protein-Arginine Deiminases | 1 | 2018 | 85 | 0.150 |
Why?
|
| CD4 Antigens | 3 | 2004 | 156 | 0.150 |
Why?
|
| Lymphadenopathy | 1 | 2017 | 23 | 0.150 |
Why?
|
| Base Sequence | 6 | 2014 | 1311 | 0.150 |
Why?
|
| Transcription Elongation, Genetic | 1 | 2017 | 1 | 0.140 |
Why?
|
| Sulfonamides | 2 | 2018 | 123 | 0.140 |
Why?
|
| Cyclin-Dependent Kinase 9 | 1 | 2017 | 6 | 0.140 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2018 | 87 | 0.140 |
Why?
|
| Core Binding Factor beta Subunit | 1 | 2017 | 20 | 0.140 |
Why?
|
| Recurrence | 2 | 2022 | 577 | 0.140 |
Why?
|
| Tumor Microenvironment | 1 | 2018 | 143 | 0.140 |
Why?
|
| Cell Line, Transformed | 1 | 2017 | 97 | 0.140 |
Why?
|
| Calcium | 1 | 2001 | 552 | 0.140 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 55 | 0.140 |
Why?
|
| STAT Transcription Factors | 1 | 2017 | 18 | 0.140 |
Why?
|
| Janus Kinases | 1 | 2017 | 19 | 0.140 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 404 | 0.140 |
Why?
|
| Fibrosis | 1 | 2017 | 151 | 0.140 |
Why?
|
| Interleukin-7 | 1 | 2017 | 30 | 0.140 |
Why?
|
| Models, Biological | 5 | 2016 | 1141 | 0.140 |
Why?
|
| Lymphocyte Activation | 2 | 2018 | 739 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-abl | 1 | 2016 | 5 | 0.140 |
Why?
|
| Autoantibodies | 1 | 2017 | 175 | 0.140 |
Why?
|
| Naphthyridines | 1 | 2016 | 6 | 0.140 |
Why?
|
| Interferon-beta | 1 | 2017 | 76 | 0.140 |
Why?
|
| Transcription Factor TFIIIA | 1 | 2016 | 6 | 0.140 |
Why?
|
| Radiation, Ionizing | 1 | 2016 | 16 | 0.140 |
Why?
|
| Gene Expression Regulation | 2 | 2018 | 1537 | 0.140 |
Why?
|
| Stress, Physiological | 1 | 2018 | 186 | 0.130 |
Why?
|
| Tissue Banks | 1 | 2016 | 4 | 0.130 |
Why?
|
| Cytoprotection | 1 | 2016 | 18 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 525 | 0.130 |
Why?
|
| Citric Acid Cycle | 1 | 2016 | 26 | 0.130 |
Why?
|
| Computational Biology | 1 | 2018 | 325 | 0.130 |
Why?
|
| Cysteine Endopeptidases | 1 | 2016 | 90 | 0.130 |
Why?
|
| Tumor Necrosis Factors | 2 | 2014 | 8 | 0.130 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 2 | 2016 | 43 | 0.130 |
Why?
|
| Cell Differentiation | 3 | 2010 | 1293 | 0.130 |
Why?
|
| Axons | 1 | 2016 | 120 | 0.130 |
Why?
|
| Membrane Glycoproteins | 3 | 2004 | 667 | 0.130 |
Why?
|
| Fibroblasts | 5 | 2016 | 370 | 0.120 |
Why?
|
| Neoplasm Transplantation | 2 | 2016 | 159 | 0.120 |
Why?
|
| Leukemia, Experimental | 2 | 2016 | 19 | 0.120 |
Why?
|
| High-Throughput Screening Assays | 1 | 2016 | 73 | 0.120 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2016 | 254 | 0.120 |
Why?
|
| Zebrafish | 4 | 2022 | 323 | 0.120 |
Why?
|
| NF-kappa B p50 Subunit | 2 | 2006 | 22 | 0.120 |
Why?
|
| Cell Transdifferentiation | 1 | 2014 | 11 | 0.120 |
Why?
|
| Software | 1 | 2018 | 367 | 0.120 |
Why?
|
| Estrogen Antagonists | 1 | 2014 | 16 | 0.120 |
Why?
|
| B-Lymphocytes | 1 | 2017 | 550 | 0.120 |
Why?
|
| Fatty Liver | 1 | 2015 | 97 | 0.120 |
Why?
|
| G-Quadruplexes | 1 | 2014 | 6 | 0.120 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2014 | 86 | 0.120 |
Why?
|
| Eukaryotic Initiation Factor-4A | 1 | 2014 | 8 | 0.120 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2014 | 20 | 0.120 |
Why?
|
| Tamoxifen | 1 | 2014 | 34 | 0.120 |
Why?
|
| bcl-X Protein | 1 | 2014 | 19 | 0.120 |
Why?
|
| Microglia | 1 | 2017 | 227 | 0.120 |
Why?
|
| I-kappa B Proteins | 2 | 2005 | 38 | 0.120 |
Why?
|
| Poly I-C | 1 | 2014 | 74 | 0.120 |
Why?
|
| 5' Untranslated Regions | 1 | 2014 | 24 | 0.120 |
Why?
|
| Vaccinia | 1 | 2014 | 31 | 0.120 |
Why?
|
| Cell Cycle | 2 | 2006 | 379 | 0.120 |
Why?
|
| Oncogene Proteins | 1 | 2014 | 41 | 0.110 |
Why?
|
| Adipocytes, Brown | 1 | 2014 | 45 | 0.110 |
Why?
|
| Hepatocytes | 1 | 2015 | 191 | 0.110 |
Why?
|
| Adipose Tissue, White | 1 | 2014 | 82 | 0.110 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2006 | 291 | 0.110 |
Why?
|
| Interleukin-6 | 3 | 2004 | 309 | 0.110 |
Why?
|
| Blotting, Southern | 2 | 2010 | 52 | 0.110 |
Why?
|
| Epigenesis, Genetic | 2 | 2014 | 351 | 0.110 |
Why?
|
| Vaccinia virus | 1 | 2014 | 71 | 0.110 |
Why?
|
| Etoposide | 2 | 2011 | 35 | 0.110 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2014 | 145 | 0.110 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2015 | 167 | 0.110 |
Why?
|
| Inflammasomes | 2 | 2018 | 331 | 0.110 |
Why?
|
| Nod1 Signaling Adaptor Protein | 1 | 2013 | 12 | 0.110 |
Why?
|
| Diet, High-Fat | 1 | 2014 | 160 | 0.110 |
Why?
|
| TNF Receptor-Associated Factor 6 | 3 | 2007 | 23 | 0.110 |
Why?
|
| F-Box Proteins | 1 | 2013 | 15 | 0.110 |
Why?
|
| Weight Gain | 1 | 2014 | 161 | 0.110 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 169 | 0.110 |
Why?
|
| Treatment Failure | 1 | 2014 | 188 | 0.110 |
Why?
|
| TYK2 Kinase | 1 | 2013 | 2 | 0.110 |
Why?
|
| Transcription Factor 7-Like 1 Protein | 2 | 2004 | 5 | 0.110 |
Why?
|
| Fluorouracil | 1 | 1993 | 54 | 0.110 |
Why?
|
| STAT1 Transcription Factor | 1 | 2013 | 35 | 0.110 |
Why?
|
| Spleen | 1 | 2014 | 485 | 0.110 |
Why?
|
| Cyclin D3 | 1 | 2012 | 4 | 0.100 |
Why?
|
| Liver Neoplasms | 1 | 2015 | 276 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2012 | 10 | 0.100 |
Why?
|
| Nanog Homeobox Protein | 1 | 2012 | 10 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2012 | 16 | 0.100 |
Why?
|
| Spheroids, Cellular | 1 | 2012 | 26 | 0.100 |
Why?
|
| Mutagenesis, Insertional | 2 | 2018 | 92 | 0.100 |
Why?
|
| Virus Replication | 1 | 2014 | 302 | 0.100 |
Why?
|
| Disease Progression | 2 | 2018 | 1045 | 0.100 |
Why?
|
| Protein Stability | 3 | 2017 | 82 | 0.100 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2022 | 170 | 0.100 |
Why?
|
| Biomarkers | 1 | 2017 | 1199 | 0.100 |
Why?
|
| Bacterial Proteins | 3 | 2018 | 749 | 0.100 |
Why?
|
| Protein Biosynthesis | 1 | 2014 | 293 | 0.100 |
Why?
|
| Heme | 1 | 2012 | 27 | 0.100 |
Why?
|
| Yersinia | 2 | 2025 | 7 | 0.100 |
Why?
|
| Receptors, Cell Surface | 2 | 2004 | 439 | 0.090 |
Why?
|
| SUMO-1 Protein | 1 | 2011 | 8 | 0.090 |
Why?
|
| Exons | 2 | 2016 | 193 | 0.090 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2016 | 476 | 0.090 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2011 | 31 | 0.090 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 3 | 2007 | 23 | 0.090 |
Why?
|
| Insulin Resistance | 1 | 2014 | 404 | 0.090 |
Why?
|
| Mice, Inbred Strains | 1 | 2011 | 182 | 0.090 |
Why?
|
| Fas-Associated Death Domain Protein | 3 | 2016 | 11 | 0.090 |
Why?
|
| Imidazoles | 3 | 2019 | 83 | 0.090 |
Why?
|
| Transcription Factor 3 | 1 | 2010 | 1 | 0.090 |
Why?
|
| Reactive Oxygen Species | 1 | 2012 | 202 | 0.090 |
Why?
|
| Indoles | 3 | 2019 | 98 | 0.090 |
Why?
|
| Gonorrhea | 1 | 2013 | 196 | 0.090 |
Why?
|
| Stroke | 1 | 2020 | 1138 | 0.090 |
Why?
|
| Doxorubicin | 1 | 2011 | 99 | 0.090 |
Why?
|
| Yersinia Infections | 2 | 2025 | 9 | 0.090 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 2010 | 20 | 0.090 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2012 | 301 | 0.090 |
Why?
|
| Neisseria gonorrhoeae | 1 | 2013 | 258 | 0.090 |
Why?
|
| Retroviridae | 2 | 2006 | 72 | 0.090 |
Why?
|
| MicroRNAs | 2 | 2014 | 619 | 0.090 |
Why?
|
| Cell Separation | 1 | 2010 | 147 | 0.090 |
Why?
|
| Aneuploidy | 1 | 2010 | 37 | 0.090 |
Why?
|
| Cell Line | 3 | 2013 | 2012 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 386 | 0.090 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 2 | 2016 | 30 | 0.080 |
Why?
|
| Green Fluorescent Proteins | 1 | 2011 | 354 | 0.080 |
Why?
|
| Thymoma | 2 | 2001 | 11 | 0.080 |
Why?
|
| Embryo, Mammalian | 2 | 2014 | 161 | 0.080 |
Why?
|
| Sequence Deletion | 2 | 2024 | 114 | 0.080 |
Why?
|
| Immunoenzyme Techniques | 1 | 2009 | 104 | 0.080 |
Why?
|
| Blotting, Northern | 2 | 2010 | 148 | 0.080 |
Why?
|
| Caspase 3 | 2 | 2019 | 105 | 0.080 |
Why?
|
| Ubiquitins | 2 | 1998 | 41 | 0.080 |
Why?
|
| Endoplasmic Reticulum | 2 | 2018 | 167 | 0.080 |
Why?
|
| Bone Neoplasms | 2 | 2025 | 117 | 0.080 |
Why?
|
| Bone Marrow Cells | 3 | 2014 | 231 | 0.070 |
Why?
|
| Sp1 Transcription Factor | 1 | 2007 | 21 | 0.070 |
Why?
|
| Phenotype | 3 | 2017 | 1150 | 0.070 |
Why?
|
| Polyubiquitin | 1 | 2007 | 8 | 0.070 |
Why?
|
| Lymphoid Tissue | 2 | 2016 | 55 | 0.070 |
Why?
|
| Lymphocytes | 2 | 2012 | 193 | 0.070 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 70 | 0.070 |
Why?
|
| Energy Intake | 2 | 1998 | 213 | 0.070 |
Why?
|
| Interferon Regulatory Factor-7 | 1 | 2007 | 33 | 0.070 |
Why?
|
| ErbB Receptors | 1 | 2007 | 113 | 0.070 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 3 | 2012 | 123 | 0.070 |
Why?
|
| Viral Matrix Proteins | 1 | 2007 | 51 | 0.070 |
Why?
|
| Preleukemia | 1 | 2006 | 3 | 0.070 |
Why?
|
| Genes, p16 | 1 | 2006 | 6 | 0.070 |
Why?
|
| Histones | 3 | 2018 | 463 | 0.070 |
Why?
|
| S Phase | 1 | 2006 | 76 | 0.060 |
Why?
|
| Bcl-2-Like Protein 11 | 2 | 2017 | 18 | 0.060 |
Why?
|
| Wnt Proteins | 1 | 2006 | 91 | 0.060 |
Why?
|
| Antigens, Neoplasm | 1 | 2006 | 135 | 0.060 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 116 | 0.060 |
Why?
|
| Kidney | 2 | 2005 | 393 | 0.060 |
Why?
|
| Mice, Inbred NOD | 2 | 2017 | 511 | 0.060 |
Why?
|
| Antigens, Differentiation | 1 | 2005 | 141 | 0.060 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 1 | 2025 | 5 | 0.060 |
Why?
|
| Interleukin-1beta | 2 | 2019 | 264 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2017 | 796 | 0.060 |
Why?
|
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2024 | 7 | 0.060 |
Why?
|
| Glycoproteins | 1 | 2006 | 194 | 0.060 |
Why?
|
| CCCTC-Binding Factor | 1 | 2024 | 40 | 0.060 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2006 | 236 | 0.060 |
Why?
|
| Receptors, Immunologic | 1 | 2005 | 177 | 0.060 |
Why?
|
| Lectins, C-Type | 1 | 2025 | 82 | 0.060 |
Why?
|
| CD5 Antigens | 1 | 2004 | 18 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 1 | 2006 | 663 | 0.060 |
Why?
|
| Precipitin Tests | 1 | 2004 | 79 | 0.060 |
Why?
|
| Loss of Heterozygosity | 1 | 2004 | 24 | 0.060 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 2024 | 24 | 0.060 |
Why?
|
| Introns | 1 | 2024 | 106 | 0.060 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2024 | 42 | 0.060 |
Why?
|
| Amidohydrolases | 1 | 2024 | 35 | 0.060 |
Why?
|
| Mutagenesis | 2 | 2001 | 129 | 0.060 |
Why?
|
| MAP Kinase Kinase Kinase 3 | 1 | 2003 | 3 | 0.060 |
Why?
|
| Hedgehog Proteins | 1 | 2025 | 113 | 0.060 |
Why?
|
| Molecular Sequence Data | 3 | 2010 | 1973 | 0.060 |
Why?
|
| Time Factors | 2 | 2017 | 3577 | 0.050 |
Why?
|
| CD8 Antigens | 1 | 2003 | 53 | 0.050 |
Why?
|
| HEK293 Cells | 2 | 2017 | 574 | 0.050 |
Why?
|
| Transcriptome | 2 | 2016 | 329 | 0.050 |
Why?
|
| Jurkat Cells | 2 | 2017 | 102 | 0.050 |
Why?
|
| Dasatinib | 1 | 2022 | 3 | 0.050 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2024 | 157 | 0.050 |
Why?
|
| Down-Regulation | 2 | 2018 | 305 | 0.050 |
Why?
|
| Aging | 2 | 1998 | 723 | 0.050 |
Why?
|
| RNA, Long Noncoding | 1 | 2024 | 152 | 0.050 |
Why?
|
| Tyrosine | 1 | 2022 | 93 | 0.050 |
Why?
|
| RNA, Messenger | 3 | 2010 | 1469 | 0.050 |
Why?
|
| Homozygote | 1 | 2002 | 116 | 0.050 |
Why?
|
| Gene Targeting | 1 | 2002 | 82 | 0.050 |
Why?
|
| Heterozygote | 1 | 2002 | 166 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 2 | 2016 | 879 | 0.050 |
Why?
|
| Adenovirus E2 Proteins | 1 | 2001 | 2 | 0.050 |
Why?
|
| Ligases | 2 | 1998 | 26 | 0.050 |
Why?
|
| Mammals | 1 | 2022 | 204 | 0.050 |
Why?
|
| Dimerization | 1 | 2001 | 146 | 0.050 |
Why?
|
| Intracellular Fluid | 1 | 2001 | 32 | 0.050 |
Why?
|
| CRISPR-Cas Systems | 1 | 2025 | 327 | 0.050 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2001 | 39 | 0.050 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2001 | 42 | 0.040 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2001 | 72 | 0.040 |
Why?
|
| Calcium Channels | 1 | 2001 | 96 | 0.040 |
Why?
|
| Models, Neurological | 1 | 2001 | 81 | 0.040 |
Why?
|
| tau Proteins | 1 | 2001 | 104 | 0.040 |
Why?
|
| Receptors, Interleukin-1 Type I | 1 | 2019 | 9 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2001 | 141 | 0.040 |
Why?
|
| Ileum | 1 | 2019 | 20 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2019 | 75 | 0.040 |
Why?
|
| Osteochondrodysplasias | 1 | 1999 | 11 | 0.040 |
Why?
|
| Organoids | 1 | 2019 | 42 | 0.040 |
Why?
|
| Vitamin A | 1 | 1999 | 27 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2014 | 168 | 0.040 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2002 | 328 | 0.040 |
Why?
|
| Glutathione | 1 | 1999 | 51 | 0.040 |
Why?
|
| Interleukin-1 | 1 | 2019 | 155 | 0.040 |
Why?
|
| Ascorbic Acid | 1 | 1999 | 51 | 0.040 |
Why?
|
| Colonoscopy | 1 | 2019 | 103 | 0.040 |
Why?
|
| Vitamin E | 1 | 1999 | 54 | 0.040 |
Why?
|
| Aniline Compounds | 1 | 2018 | 29 | 0.040 |
Why?
|
| Phosphate-Binding Proteins | 1 | 2018 | 18 | 0.040 |
Why?
|
| Heat Shock Transcription Factors | 1 | 2018 | 12 | 0.040 |
Why?
|
| Colon | 1 | 2019 | 137 | 0.040 |
Why?
|
| eIF-2 Kinase | 1 | 2018 | 10 | 0.040 |
Why?
|
| Transcription Factor CHOP | 1 | 2018 | 6 | 0.040 |
Why?
|
| Heat-Shock Response | 1 | 2018 | 35 | 0.040 |
Why?
|
| Web Browser | 1 | 2018 | 5 | 0.040 |
Why?
|
| Failure to Thrive | 1 | 1998 | 7 | 0.040 |
Why?
|
| Transposases | 1 | 2018 | 13 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1998 | 29 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2018 | 137 | 0.040 |
Why?
|
| Hematopoiesis | 1 | 2018 | 123 | 0.040 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2018 | 38 | 0.040 |
Why?
|
| Brain Injuries | 1 | 2020 | 138 | 0.040 |
Why?
|
| Transcription Initiation Site | 1 | 2018 | 48 | 0.040 |
Why?
|
| fas Receptor | 1 | 1998 | 54 | 0.040 |
Why?
|
| Protein Multimerization | 1 | 2018 | 167 | 0.040 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 66 | 0.040 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2018 | 67 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2017 | 49 | 0.040 |
Why?
|
| Klebsiella | 1 | 2017 | 9 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2001 | 608 | 0.040 |
Why?
|
| RNA Polymerase II | 1 | 2017 | 71 | 0.040 |
Why?
|
| Gram-Negative Bacteria | 1 | 2017 | 54 | 0.030 |
Why?
|
| DNA Transposable Elements | 1 | 2018 | 127 | 0.030 |
Why?
|
| Janus Kinase Inhibitors | 1 | 2017 | 18 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2018 | 363 | 0.030 |
Why?
|
| Peptide Hydrolases | 1 | 2017 | 78 | 0.030 |
Why?
|
| HeLa Cells | 2 | 2013 | 526 | 0.030 |
Why?
|
| Phenazines | 1 | 2016 | 9 | 0.030 |
Why?
|
| Phosphoserine | 1 | 2016 | 10 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 1998 | 281 | 0.030 |
Why?
|
| RNA, Neoplasm | 1 | 1996 | 34 | 0.030 |
Why?
|
| Suppression, Genetic | 1 | 2016 | 24 | 0.030 |
Why?
|
| Deubiquitinating Enzyme CYLD | 1 | 2016 | 2 | 0.030 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2018 | 256 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2001 | 646 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 251 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2016 | 132 | 0.030 |
Why?
|
| Transcription Factor RelB | 1 | 2016 | 5 | 0.030 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 6 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-rel | 1 | 2016 | 15 | 0.030 |
Why?
|
| Ketoglutaric Acids | 1 | 2016 | 9 | 0.030 |
Why?
|
| Acyl Coenzyme A | 1 | 2016 | 9 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2017 | 506 | 0.030 |
Why?
|
| Isoquinolines | 1 | 2016 | 31 | 0.030 |
Why?
|
| Genes, p53 | 1 | 2016 | 53 | 0.030 |
Why?
|
| Imatinib Mesylate | 1 | 2016 | 32 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2018 | 322 | 0.030 |
Why?
|
| K562 Cells | 1 | 2016 | 58 | 0.030 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2016 | 136 | 0.030 |
Why?
|
| Transgenes | 1 | 1996 | 176 | 0.030 |
Why?
|
| Membrane Transport Proteins | 1 | 2016 | 120 | 0.030 |
Why?
|
| Random Allocation | 1 | 2016 | 198 | 0.030 |
Why?
|
| Piperazines | 1 | 2016 | 80 | 0.030 |
Why?
|
| Gene Library | 1 | 2016 | 99 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2015 | 190 | 0.030 |
Why?
|
| Binding Sites | 1 | 2018 | 871 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 1998 | 283 | 0.030 |
Why?
|
| Spinal Cord | 1 | 2016 | 197 | 0.030 |
Why?
|
| Alleles | 1 | 2016 | 422 | 0.030 |
Why?
|
| Proteome | 1 | 2016 | 135 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2016 | 249 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 2016 | 213 | 0.030 |
Why?
|
| Triterpenes | 1 | 2014 | 21 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2014 | 74 | 0.030 |
Why?
|
| Nucleotide Motifs | 1 | 2014 | 44 | 0.030 |
Why?
|
| Keratinocytes | 1 | 2014 | 63 | 0.030 |
Why?
|
| Yersinia pestis | 1 | 2014 | 33 | 0.030 |
Why?
|
| Adiposity | 1 | 2014 | 79 | 0.030 |
Why?
|
| Quinolines | 1 | 2014 | 38 | 0.030 |
Why?
|
| Interferons | 1 | 2014 | 63 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2014 | 230 | 0.030 |
Why?
|
| F-Box-WD Repeat-Containing Protein 7 | 1 | 2013 | 1 | 0.030 |
Why?
|
| Thermogenesis | 1 | 2014 | 108 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 847 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2013 | 27 | 0.030 |
Why?
|
| Interleukin-3 | 1 | 1993 | 21 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 192 | 0.030 |
Why?
|
| Tyrphostins | 1 | 2013 | 3 | 0.030 |
Why?
|
| Janus Kinase 3 | 1 | 2013 | 4 | 0.030 |
Why?
|
| Intestines | 1 | 2014 | 156 | 0.030 |
Why?
|
| Macrophage-1 Antigen | 1 | 1993 | 30 | 0.030 |
Why?
|
| Peptidoglycan | 1 | 2013 | 54 | 0.030 |
Why?
|
| Proviruses | 1 | 1993 | 23 | 0.030 |
Why?
|
| Dermatitis | 1 | 2013 | 29 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 2013 | 84 | 0.030 |
Why?
|
| Extremities | 1 | 2013 | 50 | 0.030 |
Why?
|
| Complement Activation | 1 | 2013 | 53 | 0.030 |
Why?
|
| Cyclin D2 | 1 | 2012 | 6 | 0.030 |
Why?
|
| Pyrroles | 1 | 2013 | 50 | 0.030 |
Why?
|
| Piperidines | 1 | 2013 | 50 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 448 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2012 | 29 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 193 | 0.030 |
Why?
|
| Retinoblastoma Protein | 1 | 2012 | 37 | 0.030 |
Why?
|
| Cell Nucleus | 2 | 2007 | 603 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2016 | 453 | 0.030 |
Why?
|
| Research Design | 1 | 2016 | 567 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2014 | 349 | 0.030 |
Why?
|
| Genes, Neoplasm | 1 | 2012 | 24 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2013 | 121 | 0.030 |
Why?
|
| Internet | 1 | 2016 | 459 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 672 | 0.030 |
Why?
|
| Ribosomes | 1 | 2014 | 153 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2013 | 147 | 0.020 |
Why?
|
| Endopeptidases | 2 | 2005 | 67 | 0.020 |
Why?
|
| Heme Oxygenase-1 | 1 | 2012 | 18 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2014 | 349 | 0.020 |
Why?
|
| Wound Healing | 1 | 2013 | 176 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2013 | 237 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2012 | 96 | 0.020 |
Why?
|
| Skin | 1 | 2014 | 356 | 0.020 |
Why?
|
| Organ Specificity | 1 | 1991 | 179 | 0.020 |
Why?
|
| Spectral Karyotyping | 1 | 2010 | 2 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2010 | 20 | 0.020 |
Why?
|
| Ikaros Transcription Factor | 1 | 2010 | 2 | 0.020 |
Why?
|
| Abelson murine leukemia virus | 1 | 1990 | 1 | 0.020 |
Why?
|
| Moloney murine leukemia virus | 1 | 1990 | 17 | 0.020 |
Why?
|
| Trisomy | 1 | 2010 | 19 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2010 | 111 | 0.020 |
Why?
|
| Wounds and Injuries | 1 | 2013 | 237 | 0.020 |
Why?
|
| Genome, Human | 1 | 2012 | 218 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 2010 | 64 | 0.020 |
Why?
|
| Organ Size | 1 | 2010 | 161 | 0.020 |
Why?
|
| Osteosarcoma | 1 | 2010 | 53 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2010 | 194 | 0.020 |
Why?
|
| Glycols | 1 | 2009 | 2 | 0.020 |
Why?
|
| Actinobacteria | 1 | 2009 | 7 | 0.020 |
Why?
|
| Mixed Function Oxygenases | 1 | 2009 | 17 | 0.020 |
Why?
|
| Models, Immunological | 1 | 2009 | 79 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2009 | 119 | 0.020 |
Why?
|
| Mycobacterium smegmatis | 1 | 2009 | 66 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2000 | 501 | 0.020 |
Why?
|
| Ribonucleases | 2 | 1998 | 31 | 0.020 |
Why?
|
| Viral Proteins | 1 | 1990 | 260 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2010 | 336 | 0.020 |
Why?
|
| Lactoglobulins | 2 | 1998 | 51 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2009 | 260 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2010 | 1576 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2007 | 55 | 0.020 |
Why?
|
| Adenosine Triphosphate | 2 | 1998 | 288 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2007 | 243 | 0.020 |
Why?
|
| Resting Phase, Cell Cycle | 1 | 2005 | 11 | 0.020 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2005 | 29 | 0.020 |
Why?
|
| G1 Phase | 1 | 2005 | 53 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 692 | 0.020 |
Why?
|
| Serine | 1 | 2005 | 83 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 182 | 0.020 |
Why?
|
| B7-2 Antigen | 1 | 2004 | 32 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2004 | 53 | 0.010 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2004 | 79 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 15762 | 0.010 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2000 | 11 | 0.010 |
Why?
|
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2000 | 7 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2000 | 160 | 0.010 |
Why?
|
| Rats, Mutant Strains | 1 | 1999 | 10 | 0.010 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 1998 | 7 | 0.010 |
Why?
|
| Administration, Oral | 1 | 1999 | 344 | 0.010 |
Why?
|
| Rabbits | 1 | 1998 | 330 | 0.010 |
Why?
|
| Cholesterol | 1 | 1999 | 255 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1998 | 321 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1998 | 305 | 0.010 |
Why?
|
| Rats | 1 | 1999 | 1913 | 0.010 |
Why?
|
| Diet | 1 | 1998 | 634 | 0.010 |
Why?
|